ANNOVIS BIO INC. COMMON STOCK
7,3750
12-ноября-24 13:37:21
15 мин. задержка
Акции
-0,2750
-3,59%
Сегодняшний диапазон
7,3200 - 7,8000
ISIN
N/A
Источник
NYSE
- Котировки
- Графики
Новости
- Статистика
-
12 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
11 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
07 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
22 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
15 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
03 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
02 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
30 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
05 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
15 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
06 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
24 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
09 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
02 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
18 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >